Trial intelligence / Profile preview

Botox for Base-of-thumb Osteoarthritis

NCT03187626Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Nov 2018
Primary completion
Feb 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in Osteoarthritis of the first carpometacarpal joint, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2018; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Osteoarthritis of the first carpometacarpal joint

Beyond the preview

Go deeper on NCT03187626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03187626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call